Skip to main content

Main menu

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons

User menu

  • Subscribe
  • Log in

Search

  • Advanced search
The Journal of Immunology
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons
  • Subscribe
  • Log in
The Journal of Immunology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Follow The Journal of Immunology on Twitter
  • Follow The Journal of Immunology on RSS

Cell-Extrinsic TNF Collaborates with TRIF Signaling To Promote Yersinia-Induced Apoptosis

Lance W. Peterson, Naomi H. Philip, Christopher P. Dillon, John Bertin, Peter J. Gough, Douglas R. Green and Igor E. Brodsky
J Immunol November 15, 2016, 197 (10) 4110-4117; DOI: https://doi.org/10.4049/jimmunol.1601294
Lance W. Peterson
*Department of Pathobiology, University of Pennsylvania School of Veterinary Medicine, Philadelphia, PA 19104;
†Institute for Immunology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Lance W. Peterson
Naomi H. Philip
*Department of Pathobiology, University of Pennsylvania School of Veterinary Medicine, Philadelphia, PA 19104;
†Institute for Immunology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christopher P. Dillon
‡Department of Immunology, St. Jude Children’s Research Hospital, Memphis, TN 38105; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Christopher P. Dillon
John Bertin
§Pattern Recognition Receptor Discovery Performance Unit, Immuno-Inflammation Therapeutic Area, GlaxoSmithKline, Collegeville, PA 19422
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter J. Gough
§Pattern Recognition Receptor Discovery Performance Unit, Immuno-Inflammation Therapeutic Area, GlaxoSmithKline, Collegeville, PA 19422
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Peter J. Gough
Douglas R. Green
‡Department of Immunology, St. Jude Children’s Research Hospital, Memphis, TN 38105; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Igor E. Brodsky
*Department of Pathobiology, University of Pennsylvania School of Veterinary Medicine, Philadelphia, PA 19104;
†Institute for Immunology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Igor E. Brodsky
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF + SI
  • PDF
Loading

Abstract

Innate immune responses that are crucial for control of infection are often targeted by microbial pathogens. Blockade of NF-κB and MAPK signaling by the Yersinia virulence factor YopJ inhibits cytokine production by innate immune cells but also triggers cell death. This cell death requires RIPK1 kinase activity and caspase-8, which are engaged by TLR4 and the adaptor protein TRIF. Nevertheless, TLR4- and TRIF-deficient cells undergo significant apoptosis, implicating TLR4/TRIF-independent pathways in the death of Yersinia-infected cells. In this article, we report a key role for TNF/TNFR1 in Yersinia-induced cell death of murine macrophages, which occurs despite the blockade of NF-κB and MAPK signaling imposed by Yersinia on infected cells. Intriguingly, direct analysis of YopJ injection revealed a heterogeneous population of injection-high and injection-low cells, and demonstrated that TNF expression came from the injection-low population. Moreover, TNF production by this subpopulation was necessary for maximal apoptosis in the population of highly injected cells, and TNFR-deficient mice displayed enhanced susceptibility to Yersinia infection. These data demonstrate an important role for collaboration between TNF and pattern recognition receptor signals in promoting maximal apoptosis during bacterial infection, and demonstrate that heterogeneity in virulence factor injection and cellular responses play an important role in promoting anti-Yersinia immune defense.

Introduction

Many microbial pathogens have evolved mechanisms to inhibit innate immune signaling pathways, thereby limiting the ability of infected cells to propagate inflammatory cues such as cytokine secretion (1, 2). Of the signaling pathways frequently targeted by pathogens, NF-κB and MAPK pathways elicit key host-protective antimicrobial defenses (3). However, these signaling pathways are also coupled to prosurvival signals that limit cell death pathways activated by microbial pattern recognition and cytokine receptors (3). Inhibition of innate immune signaling can, therefore, not only result in a block in cytokine and antimicrobial effector production but also trigger cell death. This induction of cell death may be an evolutionarily ancient response to pathogen virulence factors.

The YopJ protein of pathogenic yersiniae is an acyl-transferase that belongs to a family of secreted virulence factors injected into host cells by bacterial pathogens that infect plants, insects, and higher eukaryotes (4–6). The activity of YopJ blocks MAPK and NF-κB signaling to interfere with the production of inflammatory cytokines (7–9). In the absence of YopJ, the virulence of Yersinia pseudotuberculosis is attenuated in vivo following oral infection (10). However, in addition to inhibiting cytokine production, YopJ-induced blockade of NF-κB and MAPK signaling also triggers cell death downstream of TLR4-dependent TRIF signaling (7, 11–16).

TLR4/TRIF-dependent cell death induced by YopJ requires the components of the extrinsic apoptosis pathway, specifically RIPK1, Fas-associated death domain (FADD), and caspase-8 (17–19). Interestingly, although absence of RIPK1 or caspase-8 abrogates YopJ-induced cell death, TLR4- and TRIF-deficient cells still exhibit significant, although reduced, death (13–15, 18, 19), implying that an additional TLR4/TRIF-independent signal contributes to Yersinia-induced apoptosis. However, such a pathway has not previously been described.

The TNFR superfamily comprises a number of cell surface receptors that are coupled to induction of both transcriptional and apoptotic responses (20). Notably, TNFR1 can induce extrinsic apoptosis through RIPK1 and caspase-8 in a variety of immune and parenchymal tissues (21). This response can have protective roles in the context of tumorigenesis but is pathologic in the setting of liver and intestinal damage (21, 22). In the context of infection, however, TNF is thought to act primarily as a mediator of inflammation and activator of innate immune and endothelial cells. YopJ blockade of NF-κB and MAPK activation virtually eliminates the production of TNF and other inflammatory cytokines by Yersinia-infected cells (7–9). Thus, the potential contribution of TNF signaling to Yersinia-induced cell death has never been examined.

In this article, we identify a key role for TNF in promoting Y. pseudotuberculosis–induced cell death and demonstrate that despite the greatly reduced TNF production that accompanies infection with virulent Y. pseudotuberculosis, TNF/TNFR1 is responsible for TRIF-independent apoptosis of infected cells. Intriguingly, cells undergoing apoptosis and cells producing TNF represented distinct populations. Unexpectedly, TNF-producing cells were injected with Yersinia YopJ, although to a significantly lower level than apoptotic cells. Thus, in a phenotypically heterogeneous population of infected cells, TNF production by cells that are injected but remain uninhibited by YopJ synergized with TRIF to promote maximal apoptosis in response to Yersinia infection. Finally, oral infection of TNFR1-deficient mice demonstrated a protective function for TNFR1 signaling in vivo. These findings establish an unanticipated role for cytokine responses in directing apoptosis of Yersinia-infected cells and a potential role for TNFR1-dependent apoptosis in promoting host protection against Yersinia infection.

Materials and Methods

Cell culture and infections

Bone marrow–derived macrophages (BMDMs) from C57BL/6J (Jackson), Tnfrsf1a−/− (23) (Jackson), Trif−/− (24), and Trif−/−Tnfr1−/− mice (25) were cultured and infected as previously described (19). Y. pseudotuberculosis strain IP2666 and isogenic yopJ mutant bacteria were grown overnight with aeration in 2×YT broth at 26°C. Y. pseudotuberculosis were diluted into inducing media (2×YT containing 20 mM sodium oxalate and 20 mM MgCl2) and grown with aeration for 1 h at 26°C followed by 2 h at 37°C. BMDMs were infected at a multiplicity of infection (MOI) of 20:1, unless otherwise noted. Cells were incubated at 37°C, and gentamicin (100 μg/ ml) was added 1 h post infection. The following were added 1 h before infection, where indicated: 100 μM zVAD-fmk (zVAD; SM Biochemicals), 60 μM necrostatin-1 (Nec-1; Calbiochem), 3 μM GSK2399872A (GSK’872; GlaxoSmithKline), 50 μM TAPI-2 (Sigma-Aldrich), and 80 μM dynasore (Sigma-Aldrich).

Cell death

Lactate dehydrogenase (LDH) release was measured from cell supernatants and quantified using the Cytotox96 Assay Kit (Promega) according to the manufacturer’s instructions and as previously described (19). For flow cytometry, cells were stained with the Zombie Yellow Fixable Viability Kit (BioLegend) and with CD45.2 and CD45.1 Abs (BioLegend) prior to fixation and permeabilization (BD Cytofix/Cytoperm Kit). Cells were stained for intracellular TNF (BioLegend) and cleaved caspase-3 (#9661; Cell Signaling). Flow cytometry samples were analyzed on the LSR II or LSRFortessa (BD).

Western blotting and ELISA

Cell lysates were harvested in lysis/sample buffer and run on 4–12% NuPAGE gels (Invitrogen). Proteins were transferred to a polyvinylidene difluoride membrane (Millipore) and blotted for caspase-8 (1G12; Enzo Life Sciences), caspase-3 (#9662; Cell Signaling), caspase-1 (sc-514; Santa Cruz), and β-actin (Sigma-Aldrich). Cytokine release was measured by ELISA on cell supernatants, using capture and detection Abs against TNF (430902; BioLegend) and CCL5 (500-P118 and 500-P118Bt; PeproTech).

CCF4-AM injection assay

BMDMs were infected with YopJ-deficient bacteria complemented with β-lactamase–linked YopJ or GST control expressing plasmid (pACYC). At 1 h post infection, cells were loaded with CCF4-AM (LiveBLAzer FRET-B/G Loading Kit; Invitrogen) according to the manufacturer’s instructions, including the addition of probenecid and with the modification of diluting Solution C 4-fold in HBSS. Cells were returned to 37°C and harvested for cell staining as above for TNF and cleaved caspase-3 at 2 h post infection.

Animal infections

Mice were fasted for 12–16 h and inoculated by gastric gavage with 2 × 108 CFU wild-type (Wt) Y. pseudotuberculosis (32777) from overnight culture in 2×YT containing irgasan. Tissues were collected, bead homogenized (MP Biomedical), and plated at 10-fold dilutions on LB plates containing irgasan to determine bacterial burdens (CFU per gram tissue). All animal studies were performed in accordance with University of Pennsylvania Institutional Animal Care and Use Committee approved protocols.

Video microscopy

Immortalized B6 macrophages were plated on 35-mm polymer coverslip dishes (Ibidi) 16 h prior to infection. Propidium iodide (PI) (Calbiochem) was added to the media and cells were infected with Yersinia as described above. Gentamicin was added 1 h post infection at the microscope. Cells were imaged on a Yokagawa spinning disk confocal microscope at ×63 magnification, 37°C and 5% CO2 over 4 h.

Results

Yersinia YopJ promotes TRIF-dependent and -independent apoptosis through RIPK1 kinase activity

YopJ promotes caspase-8–dependent apoptosis of innate immune cells through the inhibition of NF-κB– and MAPK-dependent prosurvival signaling (7, 12, 16–19). Although this response has been attributed to TLR4/TRIF (13–15), TRIF-deficient BMDMs still undergo significant Yersinia-induced death (14, 15, 18, 19). This finding implies a role for additional pathways in the induction of cell death. Both TRIF and death receptor signaling can promote survival, caspase-8–dependent apoptosis, or RIPK3-dependent programmed necrosis, depending on the nature of the genetic and environmental conditions present (26). We therefore sought to determine whether TRIF-independent death is also mediated by caspase-8–dependent apoptosis, or by an alternate death pathway, such as programmed necrosis. Similarly to Wt BMDMs, Trif−/− BMDMs undergo YopJ-dependent cleavage of apoptotic caspases, -8 and -3, following infection with Wt Y. pseudotuberculosis (Fig. 1A). As expected (19), the pancaspase inhibitor zVAD prevented the cleavage of caspase-8 and -3 but did not protect cells from death, suggesting that caspase inhibition induces a switch from Y. pseudotuberculosis–induced apoptosis to RIPK3-dependent programmed necrosis in both Wt and Trif−/− BMDMs (Fig. 1A, 1B, Supplemental Fig. 1). Indeed, the RIPK3 kinase inhibitor GSK’872 inhibited death of both zVAD-treated Wt and Trif−/− BMDMs infected with Y. pseudotuberculosis (Fig. 1B). Importantly, single deficiency of RIPK3 (18, 19) or GSK’872 treatment alone (Fig. 1B) has no effect on Yersinia-induced cell death of BMDMs. These data indicated that Y. pseudotuberculosis–induced cell death in both Wt and Trif−/− BMDMs is mediated by caspase-8–dependent apoptosis and is independent of RIPK3-programmed necrosis.

FIGURE 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 1.

Yersinia YopJ promotes TRIF-dependent and -independent apoptosis through RIPK1 kinase activity. (A) Wt or TRIF-deficient (Trif−/−) BMDMs were left uninfected (UI) or infected with Wt Y. pseudotuberculosis (Yp) or YopJ-deficient Y. pseudotuberculosis (ΔYopJ) for 4 h. Cell lysates were probed for caspase-8 and caspase-3 cleavage. Results are representative of two independent experiments. (B and C) Percentage of cytotoxicity was measured by LDH release from B6 and Trif−/− BMDMs infected with ΔYopJ or Yp for 4 h. The following were added 1 h before infection, where indicated: 100 μM zVAD-fmk (zVAD), 300 nM GSK’872, and 60 μM Nec-1. Error bars indicate mean ± SD of triplicates and are representative of three or more independent experiments. ND, not detected.

Whereas YopJ-induced apoptosis in Wt BMDMs requires the signaling molecule RIPK1 (18, 19), caspase-8 can mediate apoptosis via RIPK1 kinase–dependent or –independent pathways (22). Whether TRIF-independent cell death depends on RIPK1 activity is unknown. Importantly, Nec-1, a specific inhibitor of RIPK1 kinase activity, reduced YopJ-induced apoptosis of both Wt and Trif−/− BMDMs (Fig. 1C). Altogether, these data demonstrate that both the TRIF-dependent cell death and TRIF-independent cell death induced by Y. pseudotuberculosis involve RIPK1 kinase–dependent apoptosis.

TNFR1 mediates TRIF-independent apoptosis and caspase-1 cleavage during Yersinia infection

The TNFR superfamily mediates extrinsic apoptosis through recruitment and activation of FADD, RIPK1, and caspase-8 (21, 22). Given the requirement for all three of these factors in Yersinia-induced apoptosis (17–19), we therefore tested the possibility that TNF might play a role in Y. pseudotuberculosis–induced cell death. Surprisingly, despite the known blockade of TNF production by YopJ (7–9), TNFR1-deficient (Tnfr1−/−) BMDMs displayed significantly decreased cell death and caspase-3 cleavage, compared with Wt BMDMs (Fig. 2A, Supplemental Fig. 2A). Strikingly, macrophages deficient for both TRIF and TNFR1 (Trif−/−Tnfr1−/−) were also completely protected from Y. pseudotuberculosis–induced cell death, suggesting that in the absence of TRIF, the remaining cell death is caused by the TNFR pathway (Fig. 2A). BMDMs lacking both TNFR1 and TRIF signaling were completely protected from Y. pseudotuberculosis–induced death up to 8 h post infection, by which time both Tnfr1−/− and Trif−/− macrophages exhibit levels of death similar to that in WT cells (Supplemental Fig. 2B). Consistently, cleavage of caspase-8 and -3 was abrogated in the double-knockout cells but still present in either TRIF or TNFR single-deficient cells (Fig. 2B). Critically, TNF-deficient BMDMs phenocopied Tnfr1−/− cells, in that they were partially protected from cell death in response to Y. pseudotuberculosis infection, indicating that the role of TNFR1 is mediated by TNF itself (Fig. 2C, Supplemental Fig. 1).

FIGURE 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 2.

TNFR1 mediates TRIF-independent apoptosis and caspase-1 cleavage during Yersinia infection. (A) Cytotoxicity was measured by LDH release from Wt, Trif–/−, TNFR1-deficient (Tnfr1−/−), and TRIF/TNFR1-deficient (Trif−/−Tnfr1−/−) BMDMs infected with YopJ-deficient Y. pseudotuberculosis (ΔYopJ) or Wt Y. pseudotuberculosis (Yp) for 4 h. (B) Cell lysates were probed for caspase-8 and caspase-3 by Western analysis. (C) Cytotoxicity was measured by LDH release from Wt and TNF-deficient (Tnf−/−) BMDMs, as in (A). (D) Western analysis for caspase-1, as in (B). Error bars indicate mean ± SD of triplicates. Representative of three or more independent experiments. **p < 0.001, ***p < 0.0001. ND, not detected; UI, uninfected.

In addition to the activation of apoptotic caspases, Yersinia infection of unprimed BMDMs induces caspase-1 activation through a RIPK1, caspase-8, and FADD pathway (18, 19, 27, 28). This pathway of inflammasome-independent caspase-1 activation occurs downstream of TLR4/TRIF signaling during Yersinia infection (18, 19). Interestingly, we observed that either Trif−/− or Tnfr1−/− BMDMs still showed residual, albeit reduced, processing of caspase-1 following Y. pseudotuberculosis infection (Fig. 2D), suggesting that both pathways could independently mediate caspase-8–dependent caspase-1 processing. Indeed, only Trif−/−Tnfr1−/− cells did not undergo caspase-1 cleavage following Y. pseudotuberculosis infection, definitively demonstrating that caspase-1 processing in Trif−/− BMDMs was mediated by TNFR1 (Fig. 2D). Interestingly, although most BMDMs infected with Yersinia exhibited a profound blebbing of cellular membranes prior to taking up the membrane-impermeant dye PI, indicative of apoptosis (Supplemental Video 1), some cells appeared to lyse and release their cytoplasm concomitant with becoming PI positive, suggestive of pyroptosis or programmed necrosis-like morphology and kinetics (Supplemental Video 2). This observation is consistent with our previous findings that caspase-1 contributes to Yersinia-induced cell death, but is not absolutely required (19), suggesting that at least some fraction of the cells undergo pyroptosis in response to Y. pseudotuberculosis infection. Overall, these findings provide the first direct evidence, to our knowledge, that TNF/TNFR1 signaling contributes to Yersinia-induced cell death and caspase-1 processing.

Cell-extrinsic TNF promotes Yersinia-induced apoptosis

Given the well-established impact of YopJ on limiting NF-κB and MAPK signaling, which blocks production of cytokines, including TNF (7–9), we sought to determine the source of the TNF that was responsible for the Y. pseudotuberculosis–induced cell death. As expected, Y. pseudotuberculosis–infected cells secreted very low but detectable amounts of TNF compared with BMDMs infected with YopJ-deficient bacteria (Fig. 3A). Trif−/− cells secreted even less TNF compared with Wt cells (Fig. 3A). Single-cell analysis of TNF expression by flow cytometry demonstrated that, indeed, the vast majority of Y. pseudotuberculosis–infected cells produced little to no TNF and overlapped with uninfected cells; however, we observed a small but significant population of Y. pseudotuberculosis–infected cells that produced low levels of TNF in response to Y. pseudotuberculosis infection (Fig. 3B). Intriguingly, this TNF-producing population was entirely distinct from the cells undergoing apoptosis, as determined by cleaved caspase-3 staining (Fig. 3C). These data imply that a subset of cells within Y. pseudotuberculosis–infected cultures serves as the source of TNF that promotes YopJ-induced cell death in nonproducing cells. TNF could be absent in the cleaved caspase-3–positive cells because they are dying or have already released TNF owing to loss of membrane integrity at the time of the analysis. This explanation is unlikely, however, as the cells were gated on live cells that had an intact plasma membrane. Importantly, Tnfr1−/− cells exhibited no difference in their ability to produce TNF but had greatly reduced levels of cleaved caspase-3, demonstrating a key role for TNFR signaling in promoting Y. pseudotuberculosis–induced apoptosis (Fig. 3C).

FIGURE 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 3.

Cell-extrinsic TNF promotes Yersinia-induced apoptosis. (A) Soluble TNF measured by ELISA from supernatants of Wt and Trif−/− BMDMs left uninfected or infected with YopJ-deficient Y. pseudotuberculosis (ΔYopJ) or Wt Y. pseudotuberculosis (Yp). Inset indicates TNF production by Yp-infected cells. Error bars indicate mean ± SD of triplicates. (B) Wt and Tnfr1−/− BMDMs were left uninfected (gray-filled histogram) or infected with ΔYopJ (blue histogram) or Yp (red histogram). Two hours post infection, cells were stained and analyzed by flow cytometry (gated on singlet live cells). (C) Distinct populations of cells are positive for intracellular TNF or cleaved caspase-3 (casp-3). Gate frequencies represent mean ± SD of triplicates. Data are representative of three or more independent experiments. UI, uninfected.

Heterogeneous injection of YopJ leads to TNF production by a subset of infected cells

The blockade of inflammatory innate signaling and cytokine production by YopJ limits, but does not completely abrogate, production of TNF by infected cells. These TNF producers could be uninfected cells, cells that escaped injection of YopJ, or cells that are somehow resistant to the effects of YopJ. To distinguish between these possibilities, we used a YopJ–β-lactamase (BlaM) injection reporter system (29) to determine whether cells that were injected by YopJ were capable of producing TNF. This reporter system takes advantage of a compound fluorophore, CCF4-AM, which contains a β-lactam ring, and whose fluorescence properties are therefore altered in the presence of β-lactamase (29). YopJ-deficient Y. pseudotuberculosis were complemented with YopJ protein fused to β-lactamase (YopJ-Bla), which reconstituted the ability to inhibit cytokine expression and to induce apoptosis (Supplemental Fig. 3). Detection of CCF4-AM cleavage thus provided us with a way to quantitate cells specifically injected with functional YopJ protein because it was fused directly to β-lactamase. Intriguingly, we observed that under these infection conditions, all of the BMDMs in culture were injected by YopJ, but that a subset of the cells exhibited low injection (Fig. 4A). Importantly, all of these low-injection cells were negative for cleaved caspase-3 (Fig. 4B) but made up the entirety of the TNF-producing population of cells (Fig. 4C). Notably, all of the cells containing cleaved caspase-3 were highly injected, suggesting that apoptosis requires a high level of YopJ injection (Fig. 4B). Interestingly, lack of TNFR1 did not significantly alter the relative abundance of low-injection versus high-injection cells, but significantly reduced the frequency of cleaved caspase-3–positive cells (Fig. 4B). This finding suggested that TNFR1 signaling increased the likelihood that a YopJ-injected cell would undergo apoptosis.

FIGURE 4.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 4.

Heterogeneous injection of YopJ leads to TNF production by a subset of infected cells. (A–D) Wt or Tnfr1−/− BMDMs were left uninfected (UI) or infected at MOI 20 with YopJ-deficient Y. pseudotuberculosis (ΔYopJ) complemented with plasmid containing β-lactamase–linked YopJ (ΔYopJ + YopJ-Bla). (A) YopJ injection was measured by CCF4-AM cleavage and compared with (B) cleaved caspase-3 in total live cells or with (C) TNF expression in cleaved caspase-3-negative (CC3−) cells. (D) MOI was titrated from 20 to 2.5, and YopJ injection, cleaved caspase-3, and TNF were measured as above. (E and F) Frequency of TNF+ and cleaved caspase-3+ cells from (D). Frequencies represent mean ± SD of triplicates. Data are representative of two independent experiments. UI, uninfected.

The preferential production of TNF by low-injection cells could be due to levels of injected YopJ in these cells being below a threshold necessary to efficiently block cell signaling and cytokine production. To test the relationship between infection dose, cell death, and TNF production, we titrated the dose of Y. pseudotuberculosis infection down from 20 to 2.5. As expected, this resulted in a corresponding increase in the frequency of low-injection cells (Fig. 4D). There was a corresponding increase in the frequency of TNF-producing cells and a decrease in the frequency of apoptotic cells (Fig. 4D–F). Thus, although the number of TNF-producing cells rises as the MOI decreases, cell death likely decreases owing to a combination of reduced TLR stimulation at lower MOIs, together with levels of injected YopJ falling below a threshold necessary for the induction of apoptosis. Altogether, these studies demonstrate that heterogeneity in the extent of injection is present within a seemingly uniform population of cells, and that differences in injection efficiency account for the ability of a subset of cells to produce TNF, resulting in enhanced apoptosis of highly injected cells.

Membrane TNF and endocytic trafficking promote TRIF-independent apoptosis during Yersinia infection

TNF secretion is regulated transcriptionally as well as at a posttranslational step, in which trimeric TNF is assembled on the cell surface and subsequently released as a soluble cytokine by the metalloprotease TNF-α–converting enzyme (TACE) (30, 31). Of interest, both membrane-bound and soluble TNF are able to mediate many of the inflammatory effects of TNF (32–34). We therefore used a specific TACE inhibitor to test whether secreted TNF was required or whether membrane-bound TNF was sufficient to promote Y. pseudotuberculosis–induced apoptosis. As expected, TACE inhibitor treatment dramatically reduced the amount of TNF released into the cell supernatant (Fig. 5A). Surprisingly however, TACE inhibitor treatment had no impact on Y. pseudotuberculosis–induced cell death in Wt or Trif−/− cells, suggesting that surface TNF is sufficient to provide proapoptotic signals in the context of YopJ (Fig. 5B).

FIGURE 5.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 5.

Membrane TNF and endocytic trafficking promote TRIF-independent apoptosis during Yersinia infection. (A) Secreted TNF was measured by ELISA of supernatants of Wt BMDMs left untreated or treated with TAPI-2 and left uninfected or infected with YopJ-deficient Y. pseudotuberculosis (ΔYopJ) or Wt Y. pseudotuberculosis (Yp). (B) LDH release from Wt and Trif−/− BMDMs treated with TAPI-2. (C) CCL5 measured by ELISA and LDH release (D) from B6 BMDMs treated with Dynasore or vehicle control, as indicated. Error bars indicate mean ± SD of triplicates and are representative of three or more independent experiments. ND, not detected; UI, uninfected.

Although TNFR1-mediated signaling through NF-κB and MAPK pathways is initiated upon receptor ligation at the plasma membrane, internalization is thought to be required for the formation of the death-inducing signaling complex (DISC) that initiates apoptosis (35–37). Notably, activation of TRIF-dependent transcriptional responses downstream of TLR4, including the induction of type-I IFN and certain other chemokines such as CCL5, also require TLR4 endocytosis, which is mediated by dynamin (38). This is in contrast to MyD88-dependent TLR4 signaling, which occurs from the plasma membrane. As expected, blocking dynamin-mediated endocytosis potently inhibited the production of the TRIF-dependent cytokine CCL5 by Wt cells (Fig. 5C). Interestingly, this blocking also completely prevented Y. pseudotuberculosis–induced apoptosis in Wt, TRIF-deficient, and TNFR-deficient BMDMs (Fig. 5D). These data implicate dynamin-dependent endocytosis in both TNFR1- and TRIF-dependent Y. pseudotuberculosis–induced apoptosis.

Cell-extrinsic soluble or membrane-bound TNF promotes Y. pseudotuberculosis–induced apoptosis

The TACE inhibitor studies indicated that membrane TNF was sufficient to promote Y. pseudotuberculosis–induced cell death, but did not exclude the possibility that soluble TNF mediates this effect under normal circumstances. Indeed, addition of soluble TNF to Tnf−/− BMDMs fully restored Y. pseudotuberculosis–induced apoptosis to Wt levels (Fig. 6A, 6B). The significantly reduced levels of TNF produced by TRIF-deficient cells could potentially also account for the reduced level of apoptosis in these cells. However, although TNF addition slightly increased Y. pseudotuberculosis–induced apoptosis of Trif−/− BMDMs, it was not fully restored to Wt levels, demonstrating that TRIF and TNF play distinct, non-redundant roles in mediating Y. pseudotuberculosis–induced death (Fig. 6B).

FIGURE 6.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 6.

Cell-extrinsic TNF promotes Yersinia-induced apoptosis and in vivo antibacterial immunity. (A and B) Wt, Tnf−/−, and Trif−/− BMDMs were infected with Wt Y. pseudotuberculosis (Yp), treated with 1 ng/ml rTNF at 30 min post infection, and harvested for flow cytometric analysis of cleaved caspase-3 (casp-3) (A) or measured for LDH release (B). (C) Tnf−/− (CD45.2) and congenically marked Wt (B6.SJL, CD45.1) BMDMs were plated separately or mixed at a 19:1 (Tnf−/−/Wt) ratio and infected with Wt Yp for 2 h. Mixed cultures were analyzed by flow cytometry for cleaved caspase-3, using CD45 staining to differentiate Wt and Tnf−/− cells. Cells were treated with TAPI-2 or control media 1 h prior to infection, where indicated. Error bars indicate mean ± SD of triplicates. Data are representative of two or more independent experiments. (D) Wt and Tnfr1−/− mice were infected orally with 2 × 108 CFU Yp, and tissue bacterial burdens were measured at day 5 post infection. Line represents geometric mean of data pooled from two experiments; total n = 10–12 mice. Dashed line indicates limit of detection. *p < 0.05, **p < 0.01, ***p < 0.001.

To further test whether cell-extrinsic TNF promotes Y. pseudotuberculosis–induced apoptosis, we infected mixed cultures of BMDMs derived from TNF-deficient and Wt congenically marked bone marrow. When mixed at a 19:1 ratio of Tnf−/−/Wt cells, just 5% of Wt cells capable of producing TNF were sufficient to mediate maximal levels of apoptosis in Tnf−/− cells, demonstrating that minimal levels of TNF are required to induce cell death (Fig. 6C). Intriguingly, treatment of the 19:1 cultures with TACE inhibitor reduced apoptosis of Tnf−/− cells in the mixed cultures to nearly that of Tnf−/− cells alone (Fig. 6C). However, at a Tnf−/−/Wt ratio of 1:1, TACE inhibition had no detectable impact on cell death in Tnf−/− cells, similar to what we observed in cultures of Wt and Trif−/− BMDMs alone following TAPI treatment (Supplemental Fig. 4, Fig. 5B). This finding suggests that when cell–cell contacts are limiting, TNF secreted by Wt cells plays a key role in promoting Y. pseudotuberculosis–induced apoptosis. However, when cell–cell contact between TNF-producing and nonproducing cells is not limiting, cell surface TNF is sufficient to mediate maximal apoptosis. Collectively these studies indicate that both cell surface and soluble TNF are capable of promoting Y. pseudotuberculosis–induced apoptosis and likely have a common function during infection.

Finally, we sought to determine whether TNFR1-dependent apoptosis significantly affected control of Y. pseudotuberculosis during in vivo infection. Compared with Wt mice, Tnfr1−/− mice had increased bacterial burdens in both the spleen and liver 5 d after oral infection. This indicates an important in vivo role for TNF signaling in host defense that may depend on the induction of TNFR1-dependent apoptosis (Fig. 6D). Altogether, these results reveal a previously unappreciated role for cell-extrinsic TNF in macrophage killing during Yersinia infection and suggest that this function contributes to antibacterial immune defense.

Discussion

Cell death is a prominent feature of infection by many pathogens, including Yersinia (7, 10, 11). During Yersinia infection, cell death is triggered by the activity of YopJ, which promotes bacterial dissemination from mucosal tissues (10). However, Yersinia-induced cell death may also provide a means for infected cells to elicit inflammatory signals or induce phagocytosis of cell-associated bacteria to overcome YopJ-dependent signaling inhibition (39–41).

Although TLR4/TRIF contribute to apoptosis during Yersinia infection, significant cell death occurs in Yersinia-infected cells even in the absence of TLR4/TRIF-dependent signals (13–15). These data suggest that an additional, as-yet-undefined, pathway contributes to Yersinia-induced cell death. In this article, we show a key role for TNF signaling in promoting Yersinia-induced apoptosis, implicating innate cytokine signaling in promoting host cell death during infection. To our knowledge, this is the first direct evidence that TNF signaling contributes to Yersinia-induced macrophage apoptosis, and supports a model in which cell-extrinsic cytokine signals play an important role in mediating the death of Yersinia-infected cells.

The role of TNF in Yersinia-induced apoptosis may be particularly important because at 37°C, Yersinia alters its LPS to a form that is poorly detected by TLR4 (42–44). This feature likely limits both antibacterial cytokine responses and TLR4-dependent induction of apoptosis in vivo. Thus, additional pathways to promote apoptosis may play critical roles in host defense. Indeed, TRIF deficiency alone does not significantly affect control of Yersinia pseudotuberculosis in an in vivo oral infection model (45), and Fas/Fas ligand (FasL) contribute to apoptosis of Y. pestis–infected cells in the lung and promote control of infection (46). Our studies now demonstrate an important role for TNFR1 in control of oral Y. pseudotuberculosis infection, which contrasts both with TRIF deficiency and with previous investigations of the contribution of TNFR1 to control of Yersinia during systemic infection (45, 47). Prior studies with Y. enterocolitica found that TNFR1 played a pathologic role and that Tnfr1−/− mice were more resistant to infection (47). These differences may be due to either the Yersinia species or the route of infection.

Furthermore, although Y. pseudotuberculosis inhibits TNF production by cells that it encounters at sites of infection, the recruitment of additional effector cells offers an abundant source of TNF for inducing apoptosis and potential clearance of cells inhibited during earlier stages of infection. Newly recruited cells would likely not have been exposed to the inhibitory effects of Yersinia-injected virulence factors and may even be primed by inflammatory cues to produce TNF while entering the infected tissue. Notably, primed macrophages and monocytes respond differently when encountering Yersinia than do naive macrophages, particularly with respect to their mode of cell death (48). Although cytotoxic lymphocytes, including NK cells and adaptive T cells, contribute to the killing of Yersinia-infected cells later in infection (41), our findings suggest that innate immune cells could play an early role in inducing apoptotic cell death through cytokine-dependent signaling.

Our data revealed that heterogeneity in the level of injected YopJ and bacterial inhibition of cell signaling results in a subset of cells being able to produce TNF, despite the block in NF-κB signaling imposed by YopJ. Titrating the infection of BMDMs results in both increased TNF production and decreased apoptosis, implying that a high threshold of injected YopJ is needed to prevent cytokine production and to potentiate TNF-induced apoptosis in infected cells. In mixed cultures, only a very small fraction of TNF-producing cells is sufficient to induce maximal cell death of TNF-deficient cells, consistent with the finding that exogenous TNF also restores cell death to Tnf−/− cells. Intriguingly, titrating the ratio of TNF-sufficient and TNF-deficient cells while blocking TNF secretion revealed that limiting cell–cell contact between TNF producers and nonproducers increased the importance of secreted TNF in cell death. Thus, our data demonstrate that cell surface TNF is capable of providing the apoptotic signal if secretion is inhibited.

Our data also demonstrated a requirement for dynamin-dependent endocytosis in the induction of both TLR4/TRIF- and TNFR1-induced apoptosis. This requirement is presumably dependent on the formation of an intracellular DISC, raising the question of how extrinsic TNF might mediate its apoptotic effect when membrane bound. TNF that cannot be cleaved from the surface of cells owing to mutation of the TACE cleavage site is also capable of inducing apoptosis in TNFR-expressing cells (33). Notably, similar findings have been reported for other surface protein members of the TNF family, particularly FasL (49). FasL is expressed on activated NK cells and CD8+ T cells, and contributes to their ability to induce apoptosis of infected cells (50–52). Importantly, membrane-bound FasL is sufficient to induce Fas internalization, formation of a DISC, and apoptosis (49). Thus, the requirement for endocytosis may apply only to a receptor signaling complex, independent of death receptor ligand, for the induction of apoptosis.

Whether cell surface TNF is a primary driver of apoptosis when large amounts of TNF are being secreted, and whether it is sufficient to mediate the full extent of protection from bacterial infection in vivo remains to be determined. Overall, our results provide new insight into mechanisms governing pathogen-induced apoptosis, and highlight a previously unappreciated synergy between TLR and TNFR that regulates the response to bacterial infection.

Disclosures

J.B. and P.J.G. are employees of GlaxoSmithKline.

Acknowledgments

We thank Thirumala Devi-Kanneganti (St. Jude Children’s Research Hospital) for providing Trif−/− bone marrow, Jim Bliska (Stony Brook University, New York) for providing Yersinia strains, and Melanie Marketon (Indiana University) for providing the YopJ-BlaM and control plasmids.

Footnotes

  • This work was supported by National Institutes of Health Grants AI103062 and AI109267, by a Burroughs Wellcome Fund Investigator in the Pathogenesis of Infectious Disease Award (to I.E.B.), and by Training Program in Rheumatic Diseases Grant T32-AR007442 (to L.W.P.).

  • The online version of this article contains supplemental material.

  • Abbreviations used in this article:

    BMDM
    bone marrow–derived macrophage
    DISC
    death-inducing signaling complex
    FADD
    Fas-associated death domain
    FasL
    Fas ligand
    LDH
    lactate dehydrogenase
    MOI
    multiplicity of infection
    Nec-1
    necrostatin-1
    PI
    propidium iodide
    TACE
    TNF-α–converting enzyme
    Wt
    wild-type.

  • Received July 26, 2016.
  • Accepted September 20, 2016.
  • Copyright © 2016 by The American Association of Immunologists, Inc.

References

  1. ↵
    1. Brodsky I. E.,
    2. R. Medzhitov
    . 2009. Targeting of immune signalling networks by bacterial pathogens. Nat. Cell Biol. 11: 521–526.
    OpenUrlCrossRefPubMed
  2. ↵
    1. Reddick L. E.,
    2. N. M. Alto
    . 2014. Bacteria fighting back: how pathogens target and subvert the host innate immune system. Mol. Cell 54: 321–328.
    OpenUrlCrossRefPubMed
  3. ↵
    1. Blander J. M.
    2014. A long-awaited merger of the pathways mediating host defence and programmed cell death. Nat. Rev. Immunol. 14: 601–618.
    OpenUrlCrossRefPubMed
  4. ↵
    1. Mukherjee S.,
    2. G. Keitany,
    3. Y. Li,
    4. Y. Wang,
    5. H. L. Ball,
    6. E. J. Goldsmith,
    7. K. Orth
    . 2006. Yersinia YopJ acetylates and inhibits kinase activation by blocking phosphorylation. Science 312: 1211–1214.
    OpenUrlAbstract/FREE Full Text
    1. Mittal R.,
    2. S.-Y. Peak-Chew,
    3. H. T. McMahon
    . 2006. Acetylation of MEK2 and I kappa B kinase (IKK) activation loop residues by YopJ inhibits signaling. Proc. Natl. Acad. Sci. USA 103: 18574–18579.
    OpenUrlAbstract/FREE Full Text
  5. ↵
    1. Mukherjee S.,
    2. Y.-H. Hao,
    3. K. Orth
    . 2007. A newly discovered post-translational modification—the acetylation of serine and threonine residues. Trends Biochem. Sci. 32: 210–216.
    OpenUrlCrossRefPubMed
  6. ↵
    1. Ruckdeschel K.,
    2. S. Harb,
    3. A. Roggenkamp,
    4. M. Hornef,
    5. R. Zumbihl,
    6. S. Köhler,
    7. J. Heesemann,
    8. B. Rouot
    . 1998. Yersinia enterocolitica impairs activation of transcription factor NF-kappaB: involvement in the induction of programmed cell death and in the suppression of the macrophage tumor necrosis factor alpha production. J. Exp. Med. 187: 1069–1079.
    OpenUrlAbstract/FREE Full Text
    1. Boland A.,
    2. G. R. Cornelis
    . 1998. Role of YopP in suppression of tumor necrosis factor alpha release by macrophages during Yersinia infection. Infect. Immun. 66: 1878–1884.
    OpenUrlAbstract/FREE Full Text
  7. ↵
    1. Palmer L. E.,
    2. A. R. Pancetti,
    3. S. Greenberg,
    4. J. B. Bliska
    . 1999. YopJ of Yersinia spp. is sufficient to cause downregulation of multiple mitogen-activated protein kinases in eukaryotic cells. Infect. Immun. 67: 708–716.
    OpenUrlAbstract/FREE Full Text
  8. ↵
    1. Monack D. M.,
    2. J. Mecsas,
    3. D. Bouley,
    4. S. Falkow
    . 1998. Yersinia-induced apoptosis in vivo aids in the establishment of a systemic infection of mice. J. Exp. Med. 188: 2127–2137.
    OpenUrlAbstract/FREE Full Text
  9. ↵
    1. Monack D. M.,
    2. J. Mecsas,
    3. N. Ghori,
    4. S. Falkow
    . 1997. Yersinia signals macrophages to undergo apoptosis and YopJ is necessary for this cell death. Proc. Natl. Acad. Sci. USA 94: 10385–10390.
    OpenUrlAbstract/FREE Full Text
  10. ↵
    1. Ruckdeschel K.,
    2. O. Mannel,
    3. K. Richter,
    4. C. A. Jacobi,
    5. K. Trülzsch,
    6. B. Rouot,
    7. J. Heesemann
    . 2001. Yersinia outer protein P of Yersinia enterocolitica simultaneously blocks the nuclear factor-kappa B pathway and exploits lipopolysaccharide signaling to trigger apoptosis in macrophages. J. Immunol. 166: 1823–1831.
    OpenUrlAbstract/FREE Full Text
  11. ↵
    1. Zhang Y.,
    2. J. B. Bliska
    . 2003. Role of Toll-like receptor signaling in the apoptotic response of macrophages to Yersinia infection. Infect. Immun. 71: 1513–1519.
    OpenUrlAbstract/FREE Full Text
  12. ↵
    1. Haase R.,
    2. C. J. Kirschning,
    3. A. Sing,
    4. P. Schröttner,
    5. K. Fukase,
    6. S. Kusumoto,
    7. H. Wagner,
    8. J. Heesemann,
    9. K. Ruckdeschel
    . 2003. A dominant role of Toll-like receptor 4 in the signaling of apoptosis in bacteria-faced macrophages. J. Immunol. 171: 4294–4303.
    OpenUrlAbstract/FREE Full Text
  13. ↵
    1. Ruckdeschel K.,
    2. G. Pfaffinger,
    3. R. Haase,
    4. A. Sing,
    5. H. Weighardt,
    6. G. Häcker,
    7. B. Holzmann,
    8. J. Heesemann
    . 2004. Signaling of apoptosis through TLRs critically involves toll/IL-1 receptor domain-containing adapter inducing IFN-beta, but not MyD88, in bacteria-infected murine macrophages. J. Immunol. 173: 3320–3328.
    OpenUrlAbstract/FREE Full Text
  14. ↵
    1. Zhang Y.,
    2. A. T. Ting,
    3. K. B. Marcu,
    4. J. B. Bliska
    . 2005. Inhibition of MAPK and NF-kappa B pathways is necessary for rapid apoptosis in macrophages infected with Yersinia. J. Immunol. 174: 7939–7949.
    OpenUrlAbstract/FREE Full Text
  15. ↵
    1. Gröbner S.,
    2. I. Adkins,
    3. S. Schulz,
    4. K. Richter,
    5. S. Borgmann,
    6. S. Wesselborg,
    7. K. Ruckdeschel,
    8. O. Micheau,
    9. I. B. Autenrieth
    . 2007. Catalytically active Yersinia outer protein P induces cleavage of RIP and caspase-8 at the level of the DISC independently of death receptors in dendritic cells. Apoptosis 12: 1813–1825.
    OpenUrlCrossRefPubMed
  16. ↵
    1. Weng D.,
    2. R. Marty-Roix,
    3. S. Ganesan,
    4. M. K. Proulx,
    5. G. I. Vladimer,
    6. W. J. Kaiser,
    7. E. S. Mocarski,
    8. K. Pouliot,
    9. F. K.-M. Chan,
    10. M. A. Kelliher,
    11. et al
    . 2014. Caspase-8 and RIP kinases regulate bacteria-induced innate immune responses and cell death. Proc. Natl. Acad. Sci. USA 111: 7391–7396.
    OpenUrlAbstract/FREE Full Text
  17. ↵
    1. Philip N. H.,
    2. C. P. Dillon,
    3. A. G. Snyder,
    4. P. Fitzgerald,
    5. M. A. Wynosky-Dolfi,
    6. E. E. Zwack,
    7. B. Hu,
    8. L. Fitzgerald,
    9. E. A. Mauldin,
    10. A. M. Copenhaver,
    11. et al
    . 2014. Caspase-8 mediates caspase-1 processing and innate immune defense in response to bacterial blockade of NF-κB and MAPK signaling. Proc. Natl. Acad. Sci. USA 111: 7385–7390.
    OpenUrlAbstract/FREE Full Text
  18. ↵
    1. Walczak H.
    2013. Death receptor-ligand systems in cancer, cell death, and inflammation. Cold Spring Harb. Perspect. Biol. 5: a008698.
    OpenUrlAbstract/FREE Full Text
  19. ↵
    1. Brenner D.,
    2. H. Blaser,
    3. T. W. Mak
    . 2015. Regulation of tumour necrosis factor signalling: live or let die. Nat. Rev. Immunol. 15: 362–374.
    OpenUrlCrossRefPubMed
  20. ↵
    1. Wang L.,
    2. F. Du,
    3. X. Wang
    . 2008. TNF-alpha induces two distinct caspase-8 activation pathways. Cell 133: 693–703.
    OpenUrlCrossRefPubMed
  21. ↵
    1. Pfeffer K.,
    2. T. Matsuyama,
    3. T. M. Kündig,
    4. A. Wakeham,
    5. K. Kishihara,
    6. A. Shahinian,
    7. K. Wiegmann,
    8. P. S. Ohashi,
    9. M. Krönke,
    10. T. W. Mak
    . 1993. Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell 73: 457–467.
    OpenUrlCrossRefPubMed
  22. ↵
    1. Yamamoto M.,
    2. S. Sato,
    3. H. Hemmi,
    4. K. Hoshino,
    5. T. Kaisho,
    6. H. Sanjo,
    7. O. Takeuchi,
    8. M. Sugiyama,
    9. M. Okabe,
    10. K. Takeda,
    11. S. Akira
    . 2003. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science 301: 640–643.
    OpenUrlAbstract/FREE Full Text
  23. ↵
    1. Dillon C. P.,
    2. R. Weinlich,
    3. D. A. Rodriguez,
    4. J. G. Cripps,
    5. G. Quarato,
    6. P. Gurung,
    7. K. C. Verbist,
    8. T. L. Brewer,
    9. F. Llambi,
    10. Y.-N. Gong,
    11. et al
    . 2014. RIPK1 blocks early postnatal lethality mediated by caspase-8 and RIPK3. Cell 157: 1189–1202.
    OpenUrlCrossRefPubMed
  24. ↵
    1. Chan F. K.-M.,
    2. N. F. Luz,
    3. K. Moriwaki
    . 2015. Programmed necrosis in the cross talk of cell death and inflammation. Annu. Rev. Immunol. 33: 79–106.
    OpenUrlCrossRefPubMed
  25. ↵
    1. Lilo S.,
    2. Y. Zheng,
    3. J. B. Bliska
    . 2008. Caspase-1 activation in macrophages infected with Yersinia pestis KIM requires the type III secretion system effector YopJ. Infect. Immun. 76: 3911–3923.
    OpenUrlAbstract/FREE Full Text
  26. ↵
    1. Brodsky I. E.,
    2. N. W. Palm,
    3. S. Sadanand,
    4. M. B. Ryndak,
    5. F. S. Sutterwala,
    6. R. A. Flavell,
    7. J. B. Bliska,
    8. R. Medzhitov
    . 2010. A Yersinia effector protein promotes virulence by preventing inflammasome recognition of the type III secretion system. Cell Host Microbe 7: 376–387.
    OpenUrlCrossRefPubMed
  27. ↵
    1. Marketon M. M.,
    2. R. W. DePaolo,
    3. K. L. DeBord,
    4. B. Jabri,
    5. O. Schneewind
    . 2005. Plague bacteria target immune cells during infection. Science 309: 1739–1741.
    OpenUrlAbstract/FREE Full Text
  28. ↵
    1. Moss M. L.,
    2. S. L. C. Jin,
    3. M. E. Milla,
    4. D. M. Bickett,
    5. W. Burkhart,
    6. H. L. Carter,
    7. W. J. Chen,
    8. W. C. Clay,
    9. J. R. Didsbury,
    10. D. Hassler,
    11. et al
    . 1997. Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-α. Nature 385: 733–736.
    OpenUrlCrossRefPubMed
  29. ↵
    1. Black R. A.,
    2. C. T. Rauch,
    3. C. J. Kozlosky,
    4. J. J. Peschon,
    5. J. L. Slack,
    6. M. F. Wolfson,
    7. B. J. Castner,
    8. K. L. Stocking,
    9. P. Reddy,
    10. S. Srinivasan,
    11. et al.
    1997. A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature 385: 729–733.
    OpenUrlCrossRefPubMed
  30. ↵
    1. Grell M.,
    2. E. Douni,
    3. H. Wajant,
    4. M. Löhden,
    5. M. Clauss,
    6. B. Maxeiner,
    7. S. Georgopoulos,
    8. W. Lesslauer,
    9. G. Kollias,
    10. K. Pfizenmaier,
    11. P. Scheurich
    . 1995. The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell 83: 793–802.
    OpenUrlCrossRefPubMed
  31. ↵
    1. Perez C.,
    2. I. Albert,
    3. K. DeFay,
    4. N. Zachariades,
    5. L. Gooding,
    6. M. Kriegler
    . 1990. A nonsecretable cell surface mutant of tumor necrosis factor (TNF) kills by cell-to-cell contact. Cell 63: 251–258.
    OpenUrlCrossRefPubMed
  32. ↵
    1. Alexopoulou L.,
    2. M. Pasparakis,
    3. G. Kollias
    . 1997. A murine transmembrane tumor necrosis factor (TNF) transgene induces arthritis by cooperative p55/p75 TNF receptor signaling. Eur. J. Immunol. 27: 2588–2592.
    OpenUrlCrossRefPubMed
  33. ↵
    1. Micheau O.,
    2. J. Tschopp
    . 2003. Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 114: 181–190.
    OpenUrlCrossRefPubMed
    1. Harper N.,
    2. M. Hughes,
    3. M. MacFarlane,
    4. G. M. Cohen
    . 2003. Fas-associated death domain protein and caspase-8 are not recruited to the tumor necrosis factor receptor 1 signaling complex during tumor necrosis factor-induced apoptosis. J. Biol. Chem. 278: 25534–25541.
    OpenUrlAbstract/FREE Full Text
  34. ↵
    1. Schneider-Brachert W.,
    2. V. Tchikov,
    3. J. Neumeyer,
    4. M. Jakob,
    5. S. Winoto-Morbach,
    6. J. Held-Feindt,
    7. M. Heinrich,
    8. O. Merkel,
    9. M. Ehrenschwender,
    10. D. Adam,
    11. et al
    . 2004. Compartmentalization of TNF receptor 1 signaling: internalized TNF receptosomes as death signaling vesicles. Immunity 21: 415–428.
    OpenUrlCrossRefPubMed
  35. ↵
    1. Kagan J. C.,
    2. T. Su,
    3. T. Horng,
    4. A. Chow,
    5. S. Akira,
    6. R. Medzhitov
    . 2008. TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-beta. Nat. Immunol. 9: 361–368.
    OpenUrlCrossRefPubMed
  36. ↵
    1. Brodsky I. E.,
    2. R. Medzhitov
    . 2008. Reduced secretion of YopJ by Yersinia limits in vivo cell death but enhances bacterial virulence. PLoS Pathog. 4: e1000067.
    OpenUrlCrossRefPubMed
    1. Zauberman A.,
    2. A. Tidhar,
    3. Y. Levy,
    4. E. Bar-Haim,
    5. G. Halperin,
    6. Y. Flashner,
    7. S. Cohen,
    8. A. Shafferman,
    9. E. Mamroud
    . 2009. Yersinia pestis endowed with increased cytotoxicity is avirulent in a bubonic plague model and induces rapid protection against pneumonic plague. PLoS One 4: e5938.
    OpenUrlCrossRefPubMed
  37. ↵
    1. Bergman M. A.,
    2. W. P. Loomis,
    3. J. Mecsas,
    4. M. N. Starnbach,
    5. R. R. Isberg
    . 2009. CD8(+) T cells restrict Yersinia pseudotuberculosis infection: bypass of anti-phagocytosis by targeting antigen-presenting cells. PLoS Pathog. 5: e1000573.
    OpenUrlCrossRefPubMed
  38. ↵
    1. Knirel Y. A.,
    2. B. Lindner,
    3. E. V. Vinogradov,
    4. N. A. Kocharova,
    5. S. N. Senchenkova,
    6. R. Z. Shaikhutdinova,
    7. S. V. Dentovskaya,
    8. N. K. Fursova,
    9. I. V. Bakhteeva,
    10. G. M. Titareva,
    11. et al
    . 2005. Temperature-dependent variations and intraspecies diversity of the structure of the lipopolysaccharide of Yersinia pestis. Biochemistry 44: 1731–1743.
    OpenUrlCrossRefPubMed
    1. Rebeil R.,
    2. R. K. Ernst,
    3. B. B. Gowen,
    4. S. I. Miller,
    5. B. J. Hinnebusch
    . 2004. Variation in lipid A structure in the pathogenic yersiniae. Mol. Microbiol. 52: 1363–1373.
    OpenUrlCrossRefPubMed
  39. ↵
    1. Kawahara K.,
    2. H. Tsukano,
    3. H. Watanabe,
    4. B. Lindner,
    5. M. Matsuura
    . 2002. Modification of the structure and activity of lipid A in Yersinia pestis lipopolysaccharide by growth temperature. Infect. Immun. 70: 4092–4098.
    OpenUrlAbstract/FREE Full Text
  40. ↵
    1. Rosadini C. V.,
    2. I. Zanoni,
    3. C. Odendall,
    4. E. R. Green,
    5. M. K. Paczosa,
    6. N. H. Philip,
    7. I. E. Brodsky,
    8. J. Mecsas,
    9. J. C. Kagan
    . 2015. A single bacterial immune evasion strategy dismantles both MyD88 and TRIF signaling pathways downstream of TLR4. Cell Host Microbe 18: 682–693.
    OpenUrlCrossRefPubMed
  41. ↵
    1. Caulfield A. J.,
    2. M. E. Walker,
    3. L. M. Gielda,
    4. W. W. Lathem
    . 2014. The Pla protease of Yersinia pestis degrades fas ligand to manipulate host cell death and inflammation. Cell Host Microbe 15: 424–434.
    OpenUrlCrossRefPubMed
  42. ↵
    1. Zhao Y. X.,
    2. G. Lajoie,
    3. H. Zhang,
    4. B. Chiu,
    5. U. Payne,
    6. R. D. Inman
    . 2000. Tumor necrosis factor receptor p55-deficient mice respond to acute Yersinia enterocolitica infection with less apoptosis and more effective host resistance. Infect. Immun. 68: 1243–1251.
    OpenUrlAbstract/FREE Full Text
  43. ↵
    1. Bergsbaken T.,
    2. B. T. Cookson
    . 2007. Macrophage activation redirects yersinia-infected host cell death from apoptosis to caspase-1-dependent pyroptosis. PLoS Pathog. 3: e161.
    OpenUrlCrossRefPubMed
  44. ↵
    1. Lee K. H.,
    2. C. Feig,
    3. V. Tchikov,
    4. R. Schickel,
    5. C. Hallas,
    6. S. Schütze,
    7. M. E. Peter,
    8. A. C. Chan
    . 2006. The role of receptor internalization in CD95 signaling. EMBO J. 25: 1009–1023.
    OpenUrlAbstract/FREE Full Text
  45. ↵
    1. Suda T.,
    2. T. Okazaki,
    3. Y. Naito,
    4. T. Yokota,
    5. N. Arai,
    6. S. Ozaki,
    7. K. Nakao,
    8. S. Nagata
    . 1995. Expression of the Fas ligand in cells of T cell lineage. J. Immunol. 154: 3806–3813.
    OpenUrlAbstract
    1. Arase H.,
    2. N. Arase,
    3. T. Saito
    . 1995. Fas-mediated cytotoxicity by freshly isolated natural killer cells. J. Exp. Med. 181: 1235–1238.
    OpenUrlAbstract/FREE Full Text
  46. ↵
    1. Montel A. H.,
    2. M. R. Bochan,
    3. J. A. Hobbs,
    4. D. H. Lynch,
    5. Z. Brahmi
    . 1995. Fas involvement in cytotoxicity mediated by human NK cells. Cell. Immunol. 166: 236–246.
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

The Journal of Immunology: 197 (10)
The Journal of Immunology
Vol. 197, Issue 10
15 Nov 2016
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Advertising (PDF)
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Immunology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Cell-Extrinsic TNF Collaborates with TRIF Signaling To Promote Yersinia-Induced Apoptosis
(Your Name) has forwarded a page to you from The Journal of Immunology
(Your Name) thought you would like to see this page from the The Journal of Immunology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Cell-Extrinsic TNF Collaborates with TRIF Signaling To Promote Yersinia-Induced Apoptosis
Lance W. Peterson, Naomi H. Philip, Christopher P. Dillon, John Bertin, Peter J. Gough, Douglas R. Green, Igor E. Brodsky
The Journal of Immunology November 15, 2016, 197 (10) 4110-4117; DOI: 10.4049/jimmunol.1601294

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Cell-Extrinsic TNF Collaborates with TRIF Signaling To Promote Yersinia-Induced Apoptosis
Lance W. Peterson, Naomi H. Philip, Christopher P. Dillon, John Bertin, Peter J. Gough, Douglas R. Green, Igor E. Brodsky
The Journal of Immunology November 15, 2016, 197 (10) 4110-4117; DOI: 10.4049/jimmunol.1601294
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Disclosures
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF + SI
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Carbon Dioxide Sensing by Immune Cells Occurs through Carbonic Anhydrase 2–Dependent Changes in Intracellular pH
  • Cell-Penetrating Peptide TAT-HuR-HNS3 Suppresses Proinflammatory Gene Expression via Competitively Blocking Interaction of HuR with Its Partners
  • A Novel Ig Domain–Containing C-Type Lectin Triggers the Intestine–Hemocyte Axis to Regulate Antibacterial Immunity in Crab
Show more INNATE IMMUNITY AND INFLAMMATION

Similar Articles

Navigate

  • Home
  • Current Issue
  • Next in The JI
  • Archive
  • Brief Reviews
  • Pillars of Immunology
  • Translating Immunology

For Authors

  • Submit a Manuscript
  • Instructions for Authors
  • About the Journal
  • Journal Policies
  • Editors

General Information

  • Advertisers
  • Subscribers
  • Rights and Permissions
  • Accessibility Statement
  • FAR 889
  • Privacy Policy
  • Disclaimer

Journal Services

  • Email Alerts
  • RSS Feeds
  • ImmunoCasts
  • Twitter

Copyright © 2022 by The American Association of Immunologists, Inc.

Print ISSN 0022-1767        Online ISSN 1550-6606